Caption Management, LLC Igm Biosciences, Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$13.74 - $25.76 $549,600 - $1.03 Million	40,000 New	40,000 $549,000
Q4 2021 Feb 11, 2022	SELL	$27.59 - $66.39 $689,750 - $1.66 Million	-25,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$57.98 - $96.6 $579,800 - $966,000	10,000 Added 66.67%	25,000 $2.08 Million
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $1.07 Million - $1.82 Million	15,000 New	15,000 $1.15 Million
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $1.42 Million - $3.45 Million	-30,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$43.0 - $84.01 $1.29 Million - $2.52 Million	30,000 New	30,000 $2.21 Million

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.